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Abstract 
BACKGROUND: 
Iron overload cardiomyopathy (IOC) results from the accumulation of iron in the myocardium, and 
it is the leading cause of death in patients receiving chronic blood transfusion therapy like patients 
with thalassemia major (TM). It has been documented that adequate medical therapy can reverse 
IOC when it is diagnosed before end-stage heart failure occurs, thus underscoring the importance of 
early detection of IOC, in which speckle tracking echocardiography (STE) can play an important 
role. 
METHODS: 
154 patients from a primary thalassemia unit were screened and after applying the exclusion 
criteria, 41 patients affected by TM, receiving long-term blood transfusions every 3 weeks and 
undergoing iron chelation therapy were prospectively enrolled. 41 healthy subjects, age and sex 
matched, were included as control group. Both TM patients and control group underwent STE and 
offline software analysis. T2* CMR exam in a single center was performed in the TM group to 
assess the myocardial iron overload. 
RESULTS: 
Although average values were within normal range, patients with TM had significantly higher 
LVEDD, LV mass, LVMi, LA volume, mitral and tricuspidal A velocity, EDT, systolic pulmonary 
artery pressure (PAPs), septum Sm, and lower EF, LVEDV, LVESV, mitral and tricuspid E/A ratio 
and IVRT. The LV circumferential systolic strain was similar between groups , excepting the 
anterior and infero-septal walls (p=0.001 and 0.003 respectively), while longitudinal and radial 
systolic strain was different between controls and TM patients, being lower in the thalassemia 
group, almost for all segments of the left ventricle. Regarding strain rate (SR), when comparing the 
groups, the major difference was between radial SR at the level of the antero-septal, infero-lateral 
and antero-lateral walls (p=0.033, respectively 0.01 and 0.035). The cardiac T2* correlated only 
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with radial SR at the level of the infero-septal wall (p=0.009). The EF and FS measured with echo 
and CMR correlates well with T2* (p=0.001 and 0.002 for echo, respectively 0.026 and 0.007 for 
CMR). The longitudinal and circumferential global systolic strain was similar between control and 
thalassemic group (20.06+/-1.53% vs. 20.8+/-2.66%, p=0.09 and 19.9+/-2.08% vs. 18.96+/-2.72%, 
p=0.11) while radial global systolic strain was significantly lower in thalassemic patients (27.9+/-
4.53% vs. 21.5+/-7.9%, p<0.001). 
CONCLUSIONS: 
IOC is a potentially lethal, but treatable disease when diagnosed and treated early in its course. 
Iron studies, cardiac MRI with T2* measurement, echocardiographic assessment, and plasma BNP 
levels are all important diagnostic and prognostic tools to evaluate patients with iron-overload 
cardiomyopathy. Once heart failure develops, the prognosis is usually poor with precipitous 
deterioration and death, despite intensive chelation. 
Conventional echo parameters do not provide enough informations for early ventricular 
dysfunction. 2D strain imaging is one of the latest techniques and may provide additional data for 
management of thalassemic patients suspected of iron cardiomyopathy. 
The major advantage of 2D strain over conventional echo parameters is its superiority in detecting 
the subclinical cardiac involvement and the fact that is not affected by age and volume load and 
being not angle-dependent. 
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1. Introduction 
Thalassemia is considered the most common genetic disorder worldwide1. This disorder is a 
congenital anemia that has in common deficient synthesis of one or more of the globin subunits of 
the normal human hemoglobins. The basic defect in ß-thalassemia is a reduced or absent production 
of ß-globin chains with relative excess of α-chains. The direct consequences are a net decrease in 
the hemoglobin production and an imbalance of globin chain synthesis which is the main 
determinant of clinical severity. The β-thalassemias include four clinical syndromes of increasing 
severity: two conditions are generally asymptomatic, the silent carrier state and β-thalassemia trait, 
and usually result from the inheritance of one mutant β-globin gene, and two require intensive 
medical management, thalassemia intermedia and thalassemia major (TM). The differentiation 
between thalassemia major and intermedia is essential for design of the appropriate treatment2. The 
clinical picture of ß-thalassemia major includes features that are due to the disease itself, as well as 
others that represent the consequences of therapy and are, in a sense, iatrogenic. Patients receive 
periodic blood transfusions to keep hemoglobin levels compatible with life. Blood transfusions, 
together with increased intestinal iron absorption and chronic hemolysis, determine progressive iron 
overload in different tissues with secondary hemochromatosis. The accumulation of iron, if 
untreated, causes considerable morbidity and, ultimately, leads to death and so the importance to 
assess the iron stores3-6. The iron status of patients with transfusional iron overload can be measured 
by several methods: serum ferritin; transferrin saturation; labile plasma iron (LPI) and non-
transferrin-bound iron (NTBI); liver iron concentration (LIC) by liver biopsy, hepatic magnetic 
resonance imaging (MRI), superconducting quantum interference device (SQUID) and heart iron 
concentration by cardiac MRI (CMR). Transferrin saturation correlates reasonably well with serum 
ferritin. After only a few years of transfusion, however, transferrin is usually completely saturated, 
even in well-chelated patients. Serum ferritin has, in general, been found to correlate well with iron 
stores. Several variables can interfere with the reliability of ferritin, such as chronic disease, 
malignancy, ascorbic acid deficiency and inflammatory disorders. Serial measurements of serum 
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ferritin remain a reliable parameter, as well as the easiest one, to evaluate iron overload and efficacy 
of chelation therapy. Assessment of LPI, an investigational technique which is redox-active, has the 
potential to provide a highly accurate assessment of iron burden, and several methods for measuring 
LPI have been developed.None of these methods provide an estimate of iron accumulation in the 
various organs, as its distribution is usually not homogeneous. At present, the most accurate way of 
estimating the iron burden is by direct measurement of iron concentration in the liver (LIC). The 
relationship between LIC and cardiac iron is complex. Some patients with increased LIC have 
normal cardiac iron levels, while others with cardiac iron overload may have a normal LIC. LIC is 
less important than cardiac iron in determining the immediate risk of heart failure. Needle biopsy is 
the invasive method, while noninvasive alternative methods include MRI and magnetic 
susceptometry7,8. MRI, with the advantage of avoiding radiation exposure to the patient, has been 
used by several authors to demonstrate the presence of iron in the pituitary gland, the pancreas, the 
liver, and the heart. Both MRI and magnetic susceptometry are significantly affected by iron, and 
both show changes in iron overload. However, to date, only MRI can be applied to a moving organ 
such as the heart. CMR has also disadvantages, like being expensive, claustrophobic and local 
access remains an issue. Detection of iron deposition by MRI is based upon the ability of stored 
intracellular iron to enhance the magnetic susceptibility of the tissues and the principle of T2* 
relaxation measurements. The great advantage of the cardiac MRI T2* method or its inverse, R2*, 
is that it allows the indirect assessment of the degree of iron load in the heart. Of all quantitative 
MRI techniques used for assessment of cardiac iron overload in the last few years, R2* 
measurements appear to be the most appropriate. Cardiac complications such as heart failure and 
arrhythmias, caused by the so called “iron induced” cardiomyopathy, are considered to be the 
primary cause of death in patients with β-thalassemia major. Cardiac involvement in TM is 
generally characterized by iron-induced ventricular dysfunction, leading to heart failure. The degree 
of cardiac dysfunction is considered to depend on the quantity of iron deposited in individual 
myocardial fibers and the number of fibers affected. Myocardial iron deposition is not 
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homogeneous and does not occur until other organs such as spleen and liver become saturated. Iron 
cardiomyopathy is reversible, if intensive chelation starts in time, but diagnosis is often delayed by 
the unpredictability of cardiac iron deposition and the late development of symptoms and 
echocardiographic abnormalities. A direct measurement of myocardial iron would allow early 
diagnosis and treatment and help to reduce mortality9-11. The recent studies are turning to depict the 
early stages of iron cardiomyopathy and thus the main idea of this research. The aim of this study 
was to clarify the role of cardiac imaging in the diagnosis of iron overload cardiomyopathy in 
patients with beta-thalassemia major and to set-up the usefulness of 2D strain echocardiography 
parameters in the early detection of regional myocardial disfunction of thalassemic patients. 
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2. Methods 
Study population 
The study was conducted in Taranto Hospital Department of Hematology – Microcythemia Center 
between April and July 2011. This prospective study included 41 patients affected by TM, receiving 
long-term blood transfusions every 3 weeks and undergoing iron chelation therapy and 41 healthy 
subjects, age and sex matched, included as control group. Demographic data, haematological and 
biochemistry parameters are listed in Table 1. The study was approved by local ethics committee 
and all the participants signed the informed consent. All the patients were in sinus rhythm at the 
time of the study. The exclusion criteria for both groups were: age > 10 years, thalassemia without 
transfusions, diabetes mellitus, hypertension, hypothyroidism, neoplasms, mild or severe 
valvulopathy, arrhythmias, prior cardiac surgery, implantable cardiac defibrillators or pacemakers, 
bad echo window and complete refuse of echo exam (patients who didn’t sign the informed 
consent). The blood pressure, weight, height, body surface area, NT-pro BNP and ferritin levels 
were measured in all patients. Thalassemic patients were on intense chelating therapy with 
deferipone (38%), deferoxamine (15%), deferasirox (36%) and combination deferoxamine + 
deferipone (11%). The patients enrolled in the study underwent conventional and advanced 
echocardiography and T2* CMR exam in a single center (Pisa) to assess the myocardial iron 
overload. A critical iron loading was defined as a T2* value less than the threshold of 20 ms (less 
than the lower limit value of the 95% confidence interval of the normal T2* value as described by 
Anderson et al.12), and values equal to or greater than this limit were considered to be uncritical. 
The enrolling flow chart of the study is shown in Figure 1. 
 
Echocardiography parameters 
Conventional and Tissue Doppler echocardiography 
All patients and controls underwent echocardiographic examination according to the 
recommendations of the Joint American and European Society of Echocardiography using standard 
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parasternal and apical views through a commercially available ultrasound machine - Philips iE33 
(Philips Healthcare, Bothell, WA, USA; Transducer: S5-1)) equipped with a harmonic 5-1 MHz 
variable-frequency phased-array transducer with PureWave Crystal Technology. Cardiac 
assessment was performed at 10 days after transfusion in order to obtain a stable haemodynamic 
steady-state and to minimize the influence of the anaemia to cardiac echo parameters. The patients 
rested for 15 minutes before the echocardiographic exam. All the scans were recorded to both echo 
machine and external hard drive (Toshiba STOR.E ALU2; 3.5''; 1,5TB of data). Measurements 
were performed on 3 consecutive beats and an average of these was calculated. Parasternal long-
axis view was used to obtain the following M-mode parameters: left atrial diameter (LAD), left 
ventricular end-diastolic diameters (LVEDD), LV end-systolic diameters (LVESD), diastolic 
interventricular septal thickness (IVSd), systolic interventricular septal thickness (IVSs), diastolic 
posterior wall thickness (PWd), systolic posterior wall thickness (PWs), LVFS and LVEF 
(calculated by the Teicholz method). LV mass (LVM) was calculated as 1.04× [(LVED + IVSd + 
PWd)3 − (LVED)3] ×0.8 + 0.6 while LVM index (LVMi) was calculated as LVM/body surface 
area. End systolic left atrial dimensions were measured in the parasternal axis view from the trailing 
edge of the posterior aortic–anterior left atrial complex.  
The left ventricular outflow tract (LVOT) was measured in the parasternal long-axis view according 
to standard criteria. Cardiac index (CI, liters per minute per square meter) was calculated as the 
product of LVOT area index, LVOT pulsed Doppler velocity-time integral and heart rate. Apical 
four chamber view was used to measure: LV end-diastolic volume (LVEDV) and end-systolic 
volume (LVESV) were calculated from the apical 2- and 4-chamber views using a modified 
Simpson’s method. LV ejection fraction was calculated as ejection fraction (LVEDV–
LVESV)/LVEDV × 100. Pulsed-wave Doppler imaging was performed by placing the sample 
volume at the tip level of the mitral and tricuspid leaflets in the apical four chamber view, obtaining 
in this way peak inflow early diastolic velocity (E), late diastolic atrial filling velocity (A), their 
ratio (E/A) and E-wave deceleration time (EDT). Isovolumic relaxation time (IVRT) was obtained 
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by placing the cursor of CW Doppler in the LVOT to simultaneously display the end of aortic 
ejection and the onset of mitral inflow. Color M-mode Vp and peak E velocity to Vp ratio (E/Vp) 
was performed in the apical 4-chamber view, using color flow imaging with M-mode scan line 
placed through the center of the LV inflow blood column from the mitral valve to the apex, with 
baseline shift to lower the Nyquist limit so that the central highest velocity jet is blue. MAPSE 
(mitral annular plane systolic excursion) and TAPSE (tricuspid annular plane systolic excursion), an 
index of LV and RV systolic function, was measured with M-mode in apical four-chamber view, 
placing the examination beam on the lateral mitral and tricuspidian annulus (mm). 
The tissue Doppler-based myocardial performance index of the left ventricle (Tei index) was 
calculated according to the formula: (a-b)/b, where a represents the time interval between the end 
and onset of atrioventricular valve annular diastolic velocities, and b is the duration of annular 
systolic velocity. 
Pulsed-wave Tissue Doppler Imaging (TDI) was performed with a variable frequency, 
phased-array transducer, bypassing the high-pass filter to display tissue velocities. Gains were 
minimized to allow a clear tissue signal with minimal background noise aligning the echo 
image to the annular motion. From the apical four-chamber view, the Doppler sample volume 
(20-mm axial length) was placed at the lateral tricuspid annulus as well as at the septal and 
lateral mitral annulus obtaining peak systolic myocardial velocity (Sm), early (Em) and late 
(Am) diastolic myocardial velocities. The Nyquist limit was adjusted to a velocity range of 
1.5–15cm/s. The monitor sweep speed was set at 50–100mm/s to optimize the spectral display 
of myocardial velocities. In cases having tricuspid regurgitation (TR), the RV systolic 
pressure (RVSP) was estimated from the peak TR velocity. 
 
Speckle tracking echocardiography (STE) 
The four-chamber apical plane was acquired for the assessment of LV longitudinal strain, while the 
short-axis plane at the papillary muscle level was acquired for the assessment of LV radial and 
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circumferential strain. Using customized QLab software version 8.1 (Philips Healthcare, Bothell, 
WA, USA), a speckle tracking region of interest was defined. Real time tracking of natural acoustic 
markers within the region of interest throughout the cardiac cycle allows derivation of the two-
dimensional strain and strain-rate (SR). The LV free wall and ventricular septum were respectively 
divided into three segments, while the LV short-axis plane was divided into six segments for 
quantification of regional myocardial deformation. The narrowest possible image sector angle was 
used to achieve the maximum color Doppler frame rate. The frame rates ranged from 84 to 112 fps. 
Strain rate was expressed as 1/ s. The strain data were expressed as negative % values and measured 
from systolic strain curves. All TDI and strain measurements were calculated from 3 consecutive 
cycles and an average of 3 measurements was recorded and stored on echo machine and external 
hard drive. The intraobserver and interobserver variability for strain was 5.1%, respectively 4.7%. 
The total time for one exam had an average of 24 minutes/patient for conventional echo and 38 
minutes/patient for advanced echo, including software analysis. 
 
Magnetic resonance imaging 
All CMR exams were performed in Pisa, Italy, at MRI Laboratory of the Institute of Clinical 
Physiology using a 1.5-T MRI scanner (GE Signa CV/I; General Electric, Milwaukee, 
WI, USA). A four-element cardiac phased-array receiver surface coil with breath-holding in 
expiration and ECG-gating was used for signal reception. 
For the measurements of myocardial T2*, a fast-gradient-echo multi-echo sequence was used 
with electrocardiogram triggering. Three parallel short-axis views (basal, median, and apical) of 
the LV were obtained. 
To evaluate myocardial fibrosis contrast delayed enhanced (DE) images were acquired in the 
same view used for cine MRI from 10 to 18 minutes, after Gadobutrol (1.0 mol/L) (0.2 mmoli/Kg) 
administration, using an inversion recovery segmented gradient-echo sequences. 
The images acquired were analyzed using custom-written software (Hippo Miot IFC-CNR©) 
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developed in the IDL 6.0 environment (International Patent PCT/IB2006/000880 13 April 2006). 
 
Statistical analysis 
The data analysis was made with statistical software (SPSS version 13 for Windows, Chicago, IL), 
using descriptive analysis and correlation analysis. Descriptive analysis was made in order to test 
the normality of variables distribution. Correlation analysis was applied to study the strength of a 
linear relationship between two or more quantitative variables. Continuous variables were expressed 
as mean+/-standard deviation. Student t-test was used for comparison of parametric values. 
Correlation analysis was performed with Pearson correlation analysis. Linear regression analysis 
was modeled to determine the independent determinants of indexed LV mass (LVMi) and LA, SR 
and TDI parameters. A p value <0.05 was considered statistically significant. 
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3. Results 
The study groups consisted in a 41 controls subjects, aged 31.3+/-8.3 years, 21 males and 41 
thalassemic patients, aged 33.2+/-9.4 years, 21 males. Patients with TM had lower body surface 
areas (1.62+/-0.2 m2 vs. 1.72+/-0.19 m2, p=0.009). There were no significant differences between 
groups regarding systolic and diastolic blood pressure and heart rate. Patients with TM had iron 
overload with elevated serum ferritin levels (mean value = 1636+/-1943 ng/ml) and haemoglobin 
levels at 10 days after transfusion 9.9+/-1.02 g/dl. Mean NT-pro BNP levels was 131+/-248 pg/dl. 
The T2* value, evaluated by CMR imaging with Hippo-MIOT software was 29+/-10.7 msec, with 8 
patients (20%) having a T2* < 20msec. The T2* values < 10 ms are associated with the 
development of heart failure13. 
 
Conventional and Tissue Doppler echocardiographic parameters 
All subjects had normal ejection fraction and other parameters of systolic and diastolic function. 
Although average values were within normal range, patients with TM had significantly higher 
LVEDD, LV mass, LVMi, LA volume, mitral and tricuspidal A velocity, EDT, systolic pulmonary 
artery pressure (PAPs), septum Sm, and lower EF, LVEDV, LVESV, mitral and tricuspid E/A ratio 
and IVRT (Table 2). 
 
STE parameters 
Left ventricular myocardial deformation parameters are presented in Figure 2 and 3. The LV 
circumferential systolic strain was similar between groups , excepting the anterior and infero-septal 
walls (p=0.001 and 0.003 respectively), while longitudinal and radial systolic strain was different 
between controls and TM patients, being lower in the thalassemia group, almost for all segments of 
the left ventricle. Regarding strain rate (SR), when comparing the groups, the major difference was 
between radial SR at the level of the antero-septal, infero-lateral and antero-lateral walls (p=0.033, 
respectively 0.01 and 0.035). The cardiac T2* correlated only with radial SR at the level of the 
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infero-septal wall (p=0.009). The EF and FS measured with echo and CMR correlates well with 
T2* (p=0.001 and 0.002 for echo, respectively 0.026 and 0.007 for CMR). There were no 
differences between 2 groups divided using a T2* cut-off value of 20 msec. 
The longitudinal and circumferential global systolic strain was similar between control and 
thalassemic group (20.06+/-1.53% vs. 20.8+/-2.66%, p=0.09 and 19.9+/-2.08% vs. 18.96+/-2.72%, 
p=0.11) while radial global systolic strain was significantly lower in thalassemic patients (27.9+/-
4.53% vs. 21.5+/-7.9%, p<0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
4. Conclusions 
Heart disease is the primary determinant of prognosis and survival in beta-thalassemia major. 
Myocardial iron deposition seems to be the trigger for the development of heart failure in 
thalassemia major. 
IOC is a potentially lethal, but curable disease when diagnosed and treated early in its course. 
Iron studies, cardiac MRI with T2* measurement, echocardiographic assessment, and plasma BNP 
levels are all important diagnostic and prognostic tools to evaluate patients with iron-overload 
cardiomyopathy. Once heart failure develops, the prognosis is usually poor with precipitous 
deterioration and death, despite intensive chelation. 
Myocardial iron toxicity is attributed to free radical damage, and the role of NTBI has been 
demonstrated. In asymptomatic thalassemia patients with normal myocardial mass, diastolic 
dysfunction has been found to be an early event, even while the systolic function is only mild 
impaired. Traditional diagnostic tools (i.e: electrocardiography, 24-hour tracings, echocardiography, 
nuclear studies), although routinely used, are not predictive of subsequent cardiac dysfunction. 
Echocardiography, on the other hand, is the examination of choice for routine heart evaluation. The 
role of ultrasound on a regular basis in cardiac monitoring is undoubtedly of great importance. 
Conventional echo measures of systolic and diastolic dysfunction are insensitive for detecting early 
myocardial iron overload from their dependence on loading conditions and heart rate14. However, in 
TM patients, unlike MRI, ultrasound can only depict the complications of cardiac iron overload, not 
the iron accumulation itself15-17. 
Thalassemia patients have early regional systolic and/or diastolic dysfunction even if they do not 
have overt heart failure, thus the necessity of precocious diagnosis of cardiac involvement.  
Acoustic densitometry using ultrasonic backscatter techniques was reported to be effective in early 
detection of myocardial dysfunction in asymptomatic thalassemic patients18,19. Later, echo analysis 
of echo diastolic parameters were useful in cardiac evaluation of thalassemic patients, followed by 
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TDI parameters and strain analysis20. Nowadays, myocardial deformation techniques (2D strain) 
and rotational dynamics showed great results. 
Strain rate imaging (SRI) is a way of defining local wall thickening and thinning leading to a better 
description of regional myocardial function and is helpful in early detection and quantitative 
assessment of left ventricular (LV) longitudinal systolic functions in thalassemic patients and may 
provide additional data for management of thalassemic patients suspected of iron-mediated 
cardiomyopathy. Speckle tracking echocardiography (STE), a new echocardiographic technique, is 
a promising tool which can diagnose early stages of regional systolic or diastolic dysfunction of 
either ventricle before conventional echo parameters are abnormal and can be used for quantitative 
assessment of myocardial function. STE permits an angle-independent assessment of the magnitude 
and rate of deformation in the longitudinal, radial and circumferential dimensions as they are strong 
indices of ventricular systolic and diastolic function21-25. Myocardial mechanics, including 
rotational mechanics (LV twist), is a more sensitive marker of myocardial dysfunction than 
traditional echocardiography and offers a simple alternative to cardiac MRI for assessing significant 
myocardial iron deposition26. Echocardiographic measurements of myocardial mechanics accurately 
detect the degree of myocardial iron deposition assessed by CMR T2* values27. 
Conventional echo parameters do not provide enough informations for early ventricular 
dysfunction28. 2D strain imaging is one of the latest techniques and may provide additional data for 
management of thalassemic patients suspected of iron cardiomyopathy. 
The main finding of our study was that multiple cardiac abnormalities, detectable only using new 
diagnostic tools such as 2D strain, occur in patients with beta-thalassemia major requiring long-term 
blood transfusions and undergoing iron chelation therapy despite the absence of significant 
myocardial iron overload and structural cardiovascular changes. Our study group had significantly 
higher values of LVEDD, LV mass, LVMi, LA volume, mitral and tricuspid A velocity, EDT, 
systolic pulmonary artery pressure (PAPs) and septum Sm, similar to those found by Henry et al 
and attributed by an increased cardiac output caused by chronic anaemia29. 
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In our study, all the patients had normal conventional echo parameters of systolic and diastolic 
function. However, the advanced echo parameters of speckle tracking echocardiography showed 
significantly differences between control and thalassemic patients, especially regarding the radial 
and longitudinal strain, indicating the presence of regional dysfunction. Also, we found a good 
correlation between T2* and infero-lateral radial SR, underlying the hypothesis of regional iron 
deposits. Further studies are necessary to confirm this. 
Previous articles showed that impaired longitudinal and circumferential strain and radial strain rates 
have been found in patients with significant myocardial iron overload. However, early 
abnormalities of LV myocardial function also have been observed in well chelated patients with 
TM. 
The major advantage of 2D strain over conventional echo parameters is its superiority in detecting 
the subclinical cardiac involvement and the fact that is not affected by age and volume load and 
being not angle-dependent. 
Our data have confirmed these findings, because we observed an impairment in LV radial and 
longitudinal deformation in patients without significant myocardial iron overload, suggesting that 
even a mild myocardial iron deposition could be responsible for the cardiac abnormalities and  
that radial strain may be useful to detect those patients with possible cardiac iron loading who may 
then have a CMR for further assessment. 
Longitudinal strain is mainly driven by deformation of the subendocardial fibers, circumferential 
strain results from the mid- or subepicardial fibers, and radial strain from the transmural 
deformation of all myocardial fibers. It is known that subendocardial fibers are the most vulnerable 
to myocardial damage, including hypoxemia due to anemia, and, thus, the earliest to be affected at 
the onset of myocardial involvement, preceding the abnormalities of circumferential and radial 
deformation. This could be an explanation for the wide variation of LV longitudinal and radial 
strain values obtained in our study. The assessment of myocardial deformation could be valuable in 
the early detection of cardiac involvement and, eventually, in the adjustment of iron-chelating 
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therapy in these patients. For this purpose, 2D strain, as already shown for other diseases, will be 
more accurate and reproducible than standard echocardiography and tissue Doppler imaging in the 
identification of subclinical myocardial abnormalities in these patients. 
Furthermore, the TM patients will benefit from a close follow-up with advanced echocardiography 
for an early diagnosis of iron overload cardiomyopathy. 
The limitation of the study is the small sample size in a relatively defined population of thalassemic 
patients. The new development in the field of strain, the 3D strain, can be useful in the near future 
for the assessment of these patients. Also, the extension of deformation analysis to the right 
ventricle and left atrium may be of interest, knowing that iron deposits are heterogeneous and the 
fact that the iron has been reported to be absent from the right ventricular subendocardium in some 
patients with cardiac iron overload. Problems with software analysis, vendor dependent, still remain 
a challenge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
References: 
 
1) Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad 
Sci 1998;850:251–269. 
2) Olivieri NF. The beta-thalassemia. N Engl J Med 1999;341: 99e108. 
3) Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. 
Survival and causes of death in thalassemia major. Lancet 1989;2:27e30. 
4) Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous 
thalassaemia today: prediction, prevention and management. Eur J Haematol 
2008;80:93e106. 
5) Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, et al. Survival in 
medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994; 
331:574e8. 
6) Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Heart 
failure/cardiac transplantation: myocarditis in beta-thalassemia major: a cause of heart 
failure. Circulation 1995;91:66e71. 
7) Cogliandro T, Derchi G, Mancuso L, et al; Society for the Study of Thalassemia and 
Hemoglobinopathies (SoSTE). Guideline recommendations for heart complications in 
thalassemia major. J Cardiovasc Med 2008;9:515e25. 
8) Ong ML, Hatle LK, Lai VM, Bosco J. Non-invasive cardiac assessment in beta-thalassemia 
major. Int J Clin Pract 2002; 56:345e8. 
9) Pennell DJ: T2∗ magnetic resonance and myocardial iron in thalassaemia. Ann N Y Acad 
Sci 2005;1054:373–378. 
10) Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance 
imaging and cardiac biopsy in the evaluation of heart iron overload in patients with b-
thalassemia major. Eur J Haematol 2005;75:241e7.  
22 
 
11) Pepe A, Positano V, Santarelli MF, et al. Multislice multiecho T2* cardiovascular magnetic 
resonance for detection of the heterogeneous distribution of myocardial iron overload. J 
Magn Reson Imaging 2006;23:662e8. 
12) Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke 
B, Porter J, Walker JM, Pennell DJ: Cardiovascular T2 star (T2*) magnetic resonance for 
the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22:2171-2179. 
13) Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, 
Westwood MA, Anderson LJ, Pennell DJ: Cardiac T2* magnetic resonance for prediction of 
cardiac complications in thalassemia major. Circulation. 2009;120(20):1961-8. 
14) Bosi G, Crepaz R, Gamberini MR, Fortini M, Scarcia S, Bonsante E, et al. Left ventricular 
remodelling, and systolic and diastolic function in young adults with beta-thalassemia 
major: a Doppler echocardiographic assessment and correlation with hematological data. 
Heart 2003;89:762e6. 
15) Vogel M, Anderson LJ, Holden S, Deanfield JE, Pennell DJ, Walker JM. Tissue Doppler 
echocardiography in patients with thalassemia detects early myocardial dysfunction related 
to myocardial iron overload. Eur Heart J 2003;24: 113e9. 
16) Hamdy AM. Use of strain and tissue velocity imaging for early detection of regional 
myocardial dysfunction in patients with beta thalassemia. Eur J Echocardiogr. 2007;8:102–
109. 
17) Magri D, Sciomer S, Fedele F, et al. Early impairment of myocardial function in young 
patients with β-thalassemia major. Eur J Haematol. 2008;80:515–522. 
18) Di Paola R, Di Guardo G, Lo Giudice P, Caruso V, Magnano C, Mangiameli S. Preclinical 
thalassemic cardiopathy: a study by acoustic densitometry. Ital Heart J 2003;4:413e8. 
19) Lattanzi F, Bellotti P, Picano E, Chiarella F, Mazzarisi A, Melevendi C, Forni G, Landini L, 
Distante A, Vecchio C. Quantitative ultrasonic analysis of myocardium in patients with 
thalassemia major and iron overload. Circulation. 1993 Mar;87(3):748-54 
23 
 
20) Cheung YF, Liang XC, Chan GC, Wong SJ, Ha SY. Myocardial deformation in patients 
with Beta-thalassemia major: a speckle tracking echocardiographic study. 
Echocardiography. 2010 Mar;27(3):253-9 
21) Nikitin NP, Witte KK. Application of tissue Doppler imaging in cardiology. Cardiology. 
2004;101:170–184. 
22) Yip G, Abraham T, Belohlavek M, Khandheria BK. Clinical applications of strain rate 
imaging. J Am Soc Echocardiogr. 2003;16:1334–1342. 
23) Abraham TP, Dimaano VL, Liang HY: Role of tissue Doppler and strain echocardiography 
in current clinical practice. Circulation 2007;116:2597–2609. 
24) Pavlopoulos H, Nihoyannopoulos P: Strain and strain rate deformation parameters: From 
tissue Doppler to 2D speckle tracking. Int J Cardiovasc Imaging 2008;24:479–491. 
25) Hurlburt HM, Aurigemma GP, Hill JC, et al: Direct ultrasound measurement of longitudinal, 
circumferential, and radial strain using 2-dimensional strain imaging in normal adults. 
Echocardiography 2007;24:723–731. 
26) Monte I, Buccheri S, Bottari V, Blundo A, Licciardi S, Romeo MA. Left ventricular 
rotational dynamics in Beta thalassemia major: a speckle-tracking echocardiographic study. 
J Am Soc Echocardiogr. 2012 Oct;25(10):1083-90 
27) Garceau P, Nguyen ET, Carasso S, Ross H, Pendergrast J, Moravsky G, Bruchal-Garbicz B, 
Rakowski H. Quantification of myocardial iron deposition by two-dimensional speckle 
tracking in patients with β-thalassaemia major and Blackfan-Diamond anaemia. Heart. 2011 
Mar;97(5):388-93 
28) Kremastinos DT, Tsiapras DP, Tsetsos GA, et al: Left ventricular diastolic Doppler 
characteristics in betathalassemia major. Circulation 1993;88:1127–1135. 
29) Henry WL, Nienhuis AW, Wiener M, Miller DR, Canale VC, Piomelli S. 
Echocardiographic abnormalities in patients with transfusion-dependent anemia and 
secondary myocardial iron deposition. Am J Med. 1978;64:547–555. 
24 
 
Figure 1: Flow chart of the inclusion criteria for thalassemic patients 
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Figure 2: Circumferential (left panel), radial (right panel) and longitudinal (lower panel) systolic 
strain in thalassemia patients (red) and controls (yellow). *p<0.05 vs control 
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Figure 3: Circumferential (left panel), radial (right panel) and longitudinal (lower panel) systolic 
strain rate in thalassemia patients (red) and controls (yellow). *p<0.05 vs control 
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Table 1: Demographic, haematological and biochemistry parameters of the study population 
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Table 2: Conventional and Tissue Doppler echocardiography parameters of the thalassemia patients 
and controls 
 
